335 related articles for article (PubMed ID: 34668878)
1. Combination Therapy of Long-Acting Injectable Second-Generation Antipsychotics and Oral Antipsychotics: A Retrospective Chart Review and Prescribers' Attitude Survey.
Misawa F; Amemiya A; Fujii Y; Takeuchi H
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):81-86. PubMed ID: 34668878
[TBL] [Abstract][Full Text] [Related]
2. Adherence, health care utilization, and costs between long-acting injectable and oral antipsychotic medications in South Carolina Medicaid beneficiaries with schizophrenia.
Cai C; Kozma C; Patel C; Benson C; Yunusa I; Zhao P; Reeder G; Narasimhan M; Bank RL
J Manag Care Spec Pharm; 2024 Jun; 30(6):549-559. PubMed ID: 38824623
[TBL] [Abstract][Full Text] [Related]
3. Mortality Risk Associated With Long-acting Injectable Antipsychotics: A Systematic Review and Meta-analyses of Randomized Controlled Trials.
Kishi T; Matsunaga S; Iwata N
Schizophr Bull; 2016 Nov; 42(6):1438-1445. PubMed ID: 27086079
[TBL] [Abstract][Full Text] [Related]
4. Long-acting injectable antipsychotics for the prevention of relapse in patients with recent-onset psychotic disorders: A systematic review and meta-analysis of randomized controlled trials.
Kishi T; Oya K; Iwata N
Psychiatry Res; 2016 Dec; 246():750-755. PubMed ID: 27863801
[TBL] [Abstract][Full Text] [Related]
5. Clinical evolution of patients treated with aripiprazole long-acting injectable: a preliminary, prospective, observational study.
García Álvarez JC; González Sánchez L; García Resa E; Bonete Llácer JM; Román Rodríguez A; Pecino Esquerdo B; Pérez Martínez E
Int J Psychiatry Clin Pract; 2020 Mar; 24(1):10-17. PubMed ID: 31933402
[No Abstract] [Full Text] [Related]
6. Long-acting injectable second-generation antipsychotics in first-episode psychosis: a narrative review.
Salgueiro M; Segarra R
Int Clin Psychopharmacol; 2019 Mar; 34(2):51-56. PubMed ID: 30540617
[TBL] [Abstract][Full Text] [Related]
7. Beneficial Effects of Concomitant Long-Acting Injectable Antipsychotics on Time to Rehospitalization in Patients With Treatment-Resistant Schizophrenia Receiving Clozapine: A Retrospective Cohort Study.
Tien Y; Wang XY; Huang SC; Huang HP
J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38696112
[No Abstract] [Full Text] [Related]
8. Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan.
Misawa F; Okumura Y; Takeuchi Y; Fujii Y; Takeuchi H
Schizophr Res; 2021 May; 231():42-46. PubMed ID: 33752105
[TBL] [Abstract][Full Text] [Related]
9. Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics: A Nationwide Real-World Study in Japan.
Onitsuka T; Okada T; Hasegawa N; Tsuboi T; Iga JI; Yasui-Furukori N; Yamada N; Hori H; Muraoka H; Ohi K; Ogasawara K; Ochi S; Takeshima M; Ichihashi K; Fukumoto K; Iida H; Yamada H; Furihata R; Makinodan M; Takaesu Y; Numata S; Komatsu H; Hishimoto A; Kido M; Atake K; Yamagata H; Kikuchi S; Hashimoto N; Usami M; Katsumoto E; Asami T; Kubota C; Matsumoto J; Miura K; Hirano Y; Watanabe K; Inada K; Hashimoto R
J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):365-368. PubMed ID: 37216369
[TBL] [Abstract][Full Text] [Related]
10. Association between discontinuation due to withdrawal of consent and use of long-acting injectable antipsychotics: A meta-analysis of randomized trials for schizophrenia.
Kishi T; Sakuma K; Okuya M; Iwata N
J Psychiatr Res; 2021 Jan; 132():144-150. PubMed ID: 33096355
[TBL] [Abstract][Full Text] [Related]
11. Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan.
Misawa F; Fujii Y; Takeuchi H
J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 35921512
[No Abstract] [Full Text] [Related]
12. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
[TBL] [Abstract][Full Text] [Related]
13. Impact of long-acting injectable aripiprazole on the concomitant medication and antipsychotic polypharmacy: a retrospective, observational study of 127 patients with psychosis.
Lee J; Oh S; Moon SY; Loh SK; Kim M; Lee TY; Kwon JS
Int Clin Psychopharmacol; 2024 Jul; 39(4):250-256. PubMed ID: 37982292
[TBL] [Abstract][Full Text] [Related]
14. Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study.
Buckley PF; Schooler NR; Goff DC; Hsiao J; Kopelowicz A; Lauriello J; Manschreck T; Mendelowitz AJ; Miller del D; Severe JB; Wilson DR; Ames D; Bustillo J; Mintz J; Kane JM;
Schizophr Bull; 2015 Mar; 41(2):449-59. PubMed ID: 24870446
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of concomitant oral antipsychotic drug use among patients treated with long-acting, intramuscular, antipsychotic medications.
Aggarwal NK; Sernyak MJ; Rosenheck RA
J Clin Psychopharmacol; 2012 Jun; 32(3):323-8. PubMed ID: 22544006
[TBL] [Abstract][Full Text] [Related]
16. Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics.
Mahlich J; Olbrich K; Wilk A; Wimmer A; Wolff-Menzler C
Clin Drug Investig; 2021 Jan; 41(1):99-113. PubMed ID: 33331979
[TBL] [Abstract][Full Text] [Related]
17. Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review.
Keramatian K; Chakrabarty T; Yatham LN
CNS Drugs; 2019 May; 33(5):431-456. PubMed ID: 30963507
[TBL] [Abstract][Full Text] [Related]
18. "Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".
Jackson JW; Fulchino L; Rogers J; Mogun H; Polinski J; Henderson DC; Schneeweiss S; Fischer MA
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):95-104. PubMed ID: 29168261
[TBL] [Abstract][Full Text] [Related]
19. Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
Maestri TJ; Mican LM; Rozea H; Barner JC
Psychopharmacol Bull; 2018 Mar; 48(3):8-15. PubMed ID: 29713100
[TBL] [Abstract][Full Text] [Related]
20. Continuation of schizophrenia treatment with three long-acting injectable antipsychotics in South Korea: A nationwide population-based study.
Joo SW; Shon SH; Choi G; Koh M; Cho SW; Lee J
Eur Neuropsychopharmacol; 2019 Sep; 29(9):1051-1060. PubMed ID: 31362852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
